Spravato Operations Series
Spravato REMS Compliance as a Workflow, Not a Binder
Setting certification, patient enrollment, the two-hour monitoring window, and who documents what — REMS treated as the operations problem it actually is.
REMS Is an Operations Problem Wearing a Compliance Costume
Because Spravato (esketamine) carries risks of sedation, dissociation, respiratory depression, and abuse potential, the FDA requires it to be dispensed and administered under a Risk Evaluation and Mitigation Strategy. Most clinics read the REMS as paperwork — forms to file, a portal to log into. That framing is why REMS causes so much friction: every REMS requirement is actually a constraint on your schedule, your staffing, your documentation, and ultimately your billing. Treat it as workflow design and it becomes routine. Treat it as a binder and it becomes the bottleneck that caps your program.
One more reason to treat it as a living system: the REMS gets modified. In 2025 alone, requirements were updated to mandate pulse oximetry monitoring equipment in certified settings, and a further modification was approved in October 2025. Whoever owns REMS in your clinic needs to re-verify current requirements against spravatorems.com on a schedule — not assume that launch-day training still describes the program.
The Three Enrollments
Healthcare Setting Certification
The clinic itself — not just the prescriber — must be certified in the SPRAVATO REMS before it can receive or administer the drug. Certification commits the setting to on-site administration, the monitoring protocol, required monitoring equipment (including a pulse oximeter), and ensuring the drug never leaves the premises with a patient. There are separate enrollment tracks for outpatient and inpatient settings.
Patient Enrollment
Each outpatient must be enrolled in the REMS with a completed Patient Enrollment Form, signed with a healthcare provider, before treatment. Operationally this belongs in your intake packet — same visit as consent and benefit verification — so no induction date is ever scheduled for an unenrolled patient.
Pharmacy Certification
If you acquire drug through the specialty-pharmacy pathway rather than buy-and-bill, the dispensing pharmacy must itself be REMS-certified, and shipments are coordinated per patient, per session. This is a scheduling dependency: a session is only real when patient, chair, staff, and drug all arrive together. More in Starting a Spravato Program.
The Two-Hour Monitoring Window Is Your Real Capacity Limit
After every dose — induction or maintenance, first session or fiftieth — the patient must be monitored on-site by a healthcare provider for at least two hours, until sedation and dissociation have resolved and the patient is stable to leave. Current requirements include blood pressure monitoring and pulse oximetry readings before, during, and toward the end of the session. The patient cannot drive until the next day, after a restful sleep, which makes ride arrangements a scheduling field, not a courtesy.
Do the capacity math honestly: with check-in, dosing, the monitoring window, and turnover, one session realistically occupies a chair for two and a half hours or more. A program’s throughput is therefore monitored chairs × staffed hours ÷ ~2.5. The 70-patient interventional psychiatry program we support in Oregon runs 12–15 sessions a day by spreading 7am–7pm slots across monitored chairs — that volume is a staffing-and-rooms design outcome, not something a receptionist can conjure from a standard 15-minute grid.
- Staffing model: A healthcare provider must be on-site and available throughout monitoring. Most programs run a monitoring nurse or equivalent covering multiple concurrent chairs, with the prescriber available — confirm your state’s rules for who may perform which parts.
- Vitals cadence: Blood pressure before dosing (with a hold threshold per the label), rechecked after administration and during the window; pulse oximetry per current REMS requirements. Build the cadence into a flowsheet so it happens the same way every session.
- Discharge criteria: A defined checklist — sedation resolved, dissociation resolved, vitals acceptable, ride confirmed — signed by the monitoring provider. “Seemed fine” is not a discharge note.
Who Documents What
REMS friction usually traces to undefined ownership. A workable split:
- Intake / front office: Patient REMS enrollment form completed and on file before the first induction date is offered; ride-home arrangement captured as a required scheduling field.
- Monitoring staff: The per-session monitoring record — dose, administration time, vitals series including pulse oximetry, adverse events, resolution, and discharge sign-off. This is also the documentation that supports your monitoring-time billing.
- Prescriber: Treatment decisions, dose changes, response assessment (PHQ-9 or equivalent), and the clinical note that ties the session to medical necessity.
- REMS owner (name one person): Portal submissions and required forms, setting re-verification when the REMS is modified, staff training records, and the quarterly self-audit that confirms the paper trail matches what actually happens in the chairs.
Where REMS Touches Scheduling and Billing
The REMS is upstream of both your calendar and your claims:
- Scheduling: Session length, chair count, staff coverage, drug-shipment timing (pharmacy pathway), and ride-home confirmation are all REMS-shaped constraints. Cancellations hurt more than in a normal psychiatry clinic because each slot is a 2.5-hour block, and on the pharmacy pathway a patient-labeled shipment may already be in your fridge.
- Billing: The two-hour observation is also the billable event. Medicare’s bundled G-codes (G2082/G2083) fold observation into a single payment; commercial payers commonly reimburse E/M plus prolonged clinical-staff observation codes where their policies allow — and those codes live or die on documented start and stop times. Weak monitoring documentation is simultaneously a REMS exposure and a revenue leak. Details in the Spravato billing guide.
- Authorizations: Payers may verify REMS certification during prior authorization, and consistent on-protocol delivery — which REMS-grade documentation proves — supports reauthorization. See the prior authorization playbook.
When the monitoring flowsheet, the schedule, and the auth tracker share data instead of living in three silos, REMS compliance stops being overhead — it becomes the same motion as running the program. That integration is exactly the kind of tooling we build; see custom software and automation.
Make REMS a Rhythm Instead of a Risk
We help interventional psychiatry programs turn REMS requirements into owned, repeatable workflows — with the documentation trail that satisfies auditors and supports claims.
Common Questions
What does the Spravato REMS require of a clinic?
The healthcare setting must be REMS-certified, each patient must be enrolled, the drug must be administered on-site under direct observation, and every patient must be monitored by a healthcare provider for at least two hours post-dose, with blood pressure and pulse oximetry monitoring and required documentation. Patients may not take the drug home and cannot drive until the next day after a restful sleep.
Can patients take Spravato at home?
No. Under the REMS, Spravato is dispensed and administered only in certified healthcare settings under direct observation, and the drug never leaves the premises with the patient.
Who can perform the two-hour Spravato monitoring?
The REMS requires monitoring by a healthcare provider in the certified setting. Which staff roles may perform vitals checks and monitoring tasks is additionally governed by state scope-of-practice rules, so confirm your staffing model against both the REMS and state law.
Is the two-hour monitoring billable?
Often, yes — Medicare bundles observation into G2082/G2083, and many commercial payers reimburse E/M plus prolonged clinical-staff observation codes where policy allows, supported by documented start and stop times. Exact codes and rules vary by payer; verify against each payer’s policy.
Has the Spravato REMS changed recently?
Yes. The REMS has been modified multiple times, including 2025 updates requiring pulse oximetry equipment and readings and a further modification approved in October 2025. Assign one person to re-verify current requirements at spravatorems.com on a recurring schedule.